HUP1100641A2 - A new diaza-benzofluoranthene derivate as drug - Google Patents

A new diaza-benzofluoranthene derivate as drug

Info

Publication number
HUP1100641A2
HUP1100641A2 HU1100641A HUP1100641A HUP1100641A2 HU P1100641 A2 HUP1100641 A2 HU P1100641A2 HU 1100641 A HU1100641 A HU 1100641A HU P1100641 A HUP1100641 A HU P1100641A HU P1100641 A2 HUP1100641 A2 HU P1100641A2
Authority
HU
Hungary
Prior art keywords
benzofluoranthene
derivate
drug
diaza
new
Prior art date
Application number
HU1100641A
Other languages
Hungarian (hu)
Inventor
Janos Dr Eles
Istvan Borza
Karoly Dr Tihanyi
Csilla Horvath
Ottilia Dr Balazs
Judit Dr Laszy
Istvan Dr Gyertyan
Pal Dr Kocsis
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU1100641A priority Critical patent/HU230482B1/en
Priority to PCT/IB2012/056561 priority patent/WO2013076646A1/en
Publication of HUP1100641A2 publication Critical patent/HUP1100641A2/en
Publication of HU230482B1 publication Critical patent/HU230482B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU1100641A 2011-11-22 2011-11-22 A new diaza-benzofluoranthene derivate as drug HU230482B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1100641A HU230482B1 (en) 2011-11-22 2011-11-22 A new diaza-benzofluoranthene derivate as drug
PCT/IB2012/056561 WO2013076646A1 (en) 2011-11-22 2012-11-20 A new diaza-benzofluoranthene derivative as drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1100641A HU230482B1 (en) 2011-11-22 2011-11-22 A new diaza-benzofluoranthene derivate as drug

Publications (2)

Publication Number Publication Date
HUP1100641A2 true HUP1100641A2 (en) 2013-06-28
HU230482B1 HU230482B1 (en) 2016-07-28

Family

ID=89990509

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1100641A HU230482B1 (en) 2011-11-22 2011-11-22 A new diaza-benzofluoranthene derivate as drug

Country Status (2)

Country Link
HU (1) HU230482B1 (en)
WO (1) WO2013076646A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103926337A (en) * 2014-03-01 2014-07-16 江苏斯威森生物医药工程研究中心有限公司 HPLC method for measuring vinpocetine content
EP3255044B1 (en) * 2015-02-04 2020-04-01 Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory Diaza-benzofluoranthrene compounds
IL264651B (en) * 2016-08-04 2022-08-01 Harbin Pharmaceutical Group Co Ltd General Pharmaceutical Factory Salt and crystal of diaza-benzofluorane compound
EP4112053B1 (en) * 2016-10-11 2024-02-14 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) Treatment of synucleinopathies
CN114762688B (en) * 2021-01-13 2024-07-05 南京宁丹新药技术有限公司 Application of cilostazol-containing composition in cerebrovascular diseases
CN114920743B (en) * 2022-05-09 2023-08-04 南京中医药大学 Indole alkaloid and preparation method and application thereof

Also Published As

Publication number Publication date
WO2013076646A1 (en) 2013-05-30
HU230482B1 (en) 2016-07-28

Similar Documents

Publication Publication Date Title
EP2673286A4 (en) Therapeutic compounds
PT2710018T (en) New compounds
GB201118652D0 (en) New compounds
PL2776416T3 (en) Pharmaceutical compounds
IL231229A0 (en) New dihydroquinoline - 2 - one derivatives
EP2692380A4 (en) Syringe
GB201118654D0 (en) New compounds
SI2776436T1 (en) New compounds
SG11201401937YA (en) New aryl-quinoline derivatives
SG10201604667YA (en) Pharmaceutical preparation
GB201106814D0 (en) New compounds
EP2719413A4 (en) Tri-ring syringe
EP2774642A4 (en) Syringe
HK1201534A1 (en) Pharmaceutical compounds
GB201119799D0 (en) Pharmaceutical compounds
GB201105298D0 (en) Pharmaceutical preparation
HUP1100641A2 (en) A new diaza-benzofluoranthene derivate as drug
EP2771012A4 (en) New compounds
EP2731610A4 (en) Pharmaceutical combination
GB201118876D0 (en) Pharmaceutical compounds
GB201113163D0 (en) Pharmaceutical compounds
PL2691119T3 (en) Pharmaceutical preparation
EP2695613A4 (en) Analgesic
GB201118334D0 (en) Novel dosage form
EP2687212A4 (en) Medicament